Macular Telangiectasia clinical trials at UC Health
1 in progress, 0 open to eligible people
Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel)
Sorry, accepting new patients by invitation only
This study is a prospective, phase 2 extension study of participants previously enrolled in NTMT-01 and of participants enrolled in NTMT-02. This study is designed to evaluate long term safety and efficacy of the NT-501 implant in participants previously enrolled in the NTMT-01 and NTMT-02 protocols.